Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (473)
Cancellation by sponsor (240)
Cancellation or suspension (79)
Prescription medicine registration (49)
Cancellation for failure to pay annual charge (17)
Australian Public Assessment Report (AusPAR) (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2026 (28)
2025 (96)
2024 (73)
2023 (99)
2022 (70)
2021 (65)
2020 (112)
2019 (18)
2018 (68)
2017 (104)
2016 (27)
2015 (33)
2014 (13)
2013 (5)
2012 (4)
2011 (6)
2010 (16)
2009 (4)
2008 (3)
2007 (5)
2006 (2)
2005 (2)
2004 (2)
2003 (3)
2002 (2)
2001 (3)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Search

Sponsor content

868 result(s) found, displaying 591 to 600

CIPLA ETORICOXIB etoricoxib 90 mg tablet bottle (281685)

18 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ETORICOXIB etoricoxib 90 mg tablet bottle.
ETORICIP etoricoxib 90 mg tablet blister pack (281686)

18 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ETORICIP etoricoxib 90 mg tablet blister pack.
ETORICIP etoricoxib 90 mg tablet bottle (281687)

18 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ETORICIP etoricoxib 90 mg tablet bottle.
E-COXIP etoricoxib 90 mg tablet blister pack (281688)

18 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for E-COXIP etoricoxib 90 mg tablet blister pack.
E-COXIP etoricoxib 90 mg tablet bottle (281689)

18 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for E-COXIP etoricoxib 90 mg tablet bottle.
DEXEMCIP, DEXMED, DEXMEDETOMIDINE CIPLA (Cipla Australia Pty Ltd)

9 June 2020

Prescription medicine registration

Active ingredients: dexmedetomidine hydrochloride.
APO-METFORMIN 500 metformin hydrochloride 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
APO-METFORMIN 850 metformin hydrochloride 850mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
APO-METFORMIN 1000 metformin hydrochloride 1000 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

5 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
SANDOZ LAMOTRIGINE lamotrigine 25mg tablet blister pack (291469)

14 September 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SANDOZ LAMOTRIGINE lamotrigine 25mg tablet blister pack.

Pages

First page
Previous page
…
Page 56
Page 57
Page 58
Page 59
Current page 60
Page 61
Page 62
Page 63
Page 64
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.